4//SEC Filing
Portnoy Mark L. 4
Accession 0001209191-22-047881
CIK 0000862692other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 5:00 PM ET
Size
15.0 KB
Accession
0001209191-22-047881
Insider Transaction Report
Form 4
Portnoy Mark L.
DirectorCo-CEO10% Owner
Transactions
- Exercise/Conversion
Stock Option
2022-08-25$3.14/sh+59,459$186,701→ 0 totalExercise: $3.14From: 2016-04-15Exp: 2026-04-15→ Common Stock (59,459 underlying) - Exercise/Conversion
Common Stock
2022-08-25$3.14/sh+59,459$186,701→ 821,973 total
Holdings
- 20,000
Stock Option
Exercise: $7.92From: 2018-03-08Exp: 2023-03-08→ Common Stock (20,000 underlying) - 20,000
Stock Option
Exercise: $13.50From: 2021-12-22Exp: 2024-12-22→ Common Stock (20,000 underlying) - 22,222
Stock Option
Exercise: $7.53From: 2019-08-30Exp: 2029-08-30→ Common Stock (22,222 underlying) - 42,266(indirect: By 401(k))
Common Stock
- 71,529(indirect: By Partnership)
Common Stock
- 20,000
Stock Option
Exercise: $7.28From: 2019-12-20Exp: 2029-12-20→ Common Stock (20,000 underlying) - 100,000
Stock Option
Exercise: $12.27From: 2021-12-22Exp: 2028-12-22→ Common Stock (100,000 underlying)
Footnotes (4)
- [F1]Shares of Common Stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.
- [F2]The stock options are subject to the approval of the 2022 Equity Incentive Plan, which vote is expected to occur at the Company's 2022 Annual Meeting.
- [F3]One-third of the stock options will vest on December 22, 2022, one-third will vest on December 22, 2023 and one-third on December 22, 2024.
- [F4]Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven-year option term.
Documents
Issuer
CRYO CELL INTERNATIONAL INC
CIK 0000862692
Entity typeother
Related Parties
1- filerCIK 0001529249
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 5:00 PM ET
- Size
- 15.0 KB